Does Dr. CLAIRE DILLINGHAM have financial conflicts of interest?

Dr. CLAIRE DILLINGHAM (D.O.) has received a total of $91,492 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $91,492 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CLAIRE DILLINGHAM?

According to CMS Open Payments data, Dr. CLAIRE DILLINGHAM received funding from INTEGRA LIFESCIENCES CORPORATION ($63,373), AROA BIOSURGERY INCORPORATED ($21,283), and TELA BIO ($2,410).

Does Dr. CLAIRE DILLINGHAM receive research grants or speaking fees?

Dr. CLAIRE DILLINGHAM has received $91,492 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CLAIRE DILLINGHAM

D.O.Real-Time Hydrated

Specialty: Plastic Surgery

Practice Location: GREENSBORO, NC 27401

NPI Number: 1902006646

LIFETIME INDUSTRY VALUE

$91,492

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. DILLINGHAM is a verified Plastic Surgery practitioner based in GREENSBORO, NC.

Between 2021 and 2025, Dr. DILLINGHAM had an overall industry promotional and research financial footprint of $91,492 as recorded in the federal CMS Open Payments database.

$91,492 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DILLINGHAM's primary funding source is INTEGRA LIFESCIENCES CORPORATION, which accounts for $63,373 (representing 69.3% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

INTEGRA LIFESCIENCES CORPORATION

Rank 1

$63,373

69.3%

AROA BIOSURGERY INCORPORATED

Rank 2

$21,283

23.3%

TELA BIO

Rank 3

$2,410

2.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.